[A case of rectal cancer with multiple liver metastases successfully treated by repeated hepatectomy].
A 61-year-old man was diagnosed with rectal cancer with multiple liver metastases in December 2009, and low anterior resection of the rectum was performed. Postoperative adjuvant chemotherapy with 6 courses of oxaliplatin, Leucovorin, and 5-FU (FOLFOX4) and bevacizumab was initiated, followed by 5 courses of fluorouracil, Leucovorin, and irinotecan (FOLFIRI) and bevacizumab. Right posterior segment (S6, S7) hepatectomy with enucleation of S2, S3 and S5 was performed, and chemotherapy with FOLFOX4 (11 courses) was administered. New metastases in the S5 segment were observed in August 2011 and right hepatic lobectomy was performed. The patient then underwent 8 courses of adjuvant chemotherapy with FOLFOX4. However, left hepatic lobe lateral segment and caudate lobe metastases then appeared. Subsequent repeated chemotherapy with FOLFIRI plus cetuximab (3 courses) and irinotecan plus cetuximab was interrupted in August 2013 owing to adverse events resulting in rapid growth of hepatic metastases. The patient underwent hepatic left lateral segmentectomy and left caudate lobectomy. The postoperative course was uneventful and the patient has currently survived 4 years and 7 months after the initial surgery.
Dept. of Surgery, Metropolitan Health and Medical Treatment Corporation Toshima Hospital.
Masayuki
M
Ando
Kenichirou
K
Imai
Yuuichirou
Y
Matsunaga
Katsunori
K
Ami
Hideaki
H
Ganno
Hidetoshi
H
Amagasa
Nana
N
Ohshima
Akira
A
Fukuda
Takeshi
T
Nagahama
Nobuhiko
N
Aoki
Keiichi
K
Fujiya
Kuniyoshi
K
Arai
Shikofumi
S
Tei
Youichi
Y
Okada
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000473:pathology*; D016896:Treatment Outcome